1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Drug Device Combination Products Market, By Product
5.1 Introduction
5.2 Infusion Pumps
5.2.1 Insulin
5.2.2 Implantable
5.2.3 Syringe
5.2.4 Ambulatory
5.3 Orthopedic Combination Products
5.3.1 Antibiotic Bone Cement
5.3.2 Bone Graft Implants
5.4 Transdermal Patches
5.5 Photodynamic Therapy Devices
5.6 Drug Eluting Stents
5.7 Wound Care Products
5.8 Antimicrobial Catheters
5.8.1 Cardiovascular
5.8.2 Urological
5.9 Other Products
6 Global Drug Device Combination Products Market, By Application
6.1 Introduction
6.2 Diabetes
6.3 Cancer Treatment
6.4 Respiratory Problems
6.5 Other Applications
7 Global Drug Device Combination Products Market, By End User
7.1 Introduction
7.2 Home Care Settings
7.3 Ambulatory Surgery Centers
7.4 Hospitals & Clinics
7.5 Other End Users
8 Global Drug Device Combination Products Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott Laboratories
10.2 Allergan plc
10.3 Boston Scientific Corporation
10.4 C.R. Bard
10.5 Medtronic Plc
10.6 Mylan N.V.
10.7 Novartis AG
10.8 Stryker Corporation
10.9 Teleflex Incorporated
10.10 Terumo Corporation
10.11 W. L. Gore & Associates, Inc.
List of Tables
Table 1 Global Drug Device Combination Products Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Drug Device Combination Products Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Drug Device Combination Products Market Outlook, By Infusion Pumps (2021-2030) ($MN)
Table 4 Global Drug Device Combination Products Market Outlook, By Insulin (2021-2030) ($MN)
Table 5 Global Drug Device Combination Products Market Outlook, By Implantable (2021-2030) ($MN)
Table 6 Global Drug Device Combination Products Market Outlook, By Syringe (2021-2030) ($MN)
Table 7 Global Drug Device Combination Products Market Outlook, By Ambulatory (2021-2030) ($MN)
Table 8 Global Drug Device Combination Products Market Outlook, By Orthopedic Combination Products (2021-2030) ($MN)
Table 9 Global Drug Device Combination Products Market Outlook, By Antibiotic Bone Cement (2021-2030) ($MN)
Table 10 Global Drug Device Combination Products Market Outlook, By Bone Graft Implants (2021-2030) ($MN)
Table 11 Global Drug Device Combination Products Market Outlook, By Transdermal Patches (2021-2030) ($MN)
Table 12 Global Drug Device Combination Products Market Outlook, By Photodynamic Therapy Devices (2021-2030) ($MN)
Table 13 Global Drug Device Combination Products Market Outlook, By Drug Eluting Stents (2021-2030) ($MN)
Table 14 Global Drug Device Combination Products Market Outlook, By Wound Care Products (2021-2030) ($MN)
Table 15 Global Drug Device Combination Products Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
Table 16 Global Drug Device Combination Products Market Outlook, By Cardiovascular (2021-2030) ($MN)
Table 17 Global Drug Device Combination Products Market Outlook, By Urological (2021-2030) ($MN)
Table 18 Global Drug Device Combination Products Market Outlook, By Other Products (2021-2030) ($MN)
Table 19 Global Drug Device Combination Products Market Outlook, By Application (2021-2030) ($MN)
Table 20 Global Drug Device Combination Products Market Outlook, By Diabetes (2021-2030) ($MN)
Table 21 Global Drug Device Combination Products Market Outlook, By Cancer Treatment (2021-2030) ($MN)
Table 22 Global Drug Device Combination Products Market Outlook, By Respiratory Problems (2021-2030) ($MN)
Table 23 Global Drug Device Combination Products Market Outlook, By Other Applications (2021-2030) ($MN)
Table 24 Global Drug Device Combination Products Market Outlook, By End User (2021-2030) ($MN)
Table 25 Global Drug Device Combination Products Market Outlook, By Home Care Settings (2021-2030) ($MN)
Table 26 Global Drug Device Combination Products Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
Table 27 Global Drug Device Combination Products Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 28 Global Drug Device Combination Products Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
